Hyperbaric oxygen therapy—a new hope for Alzheimer’s patients: a case report and literature review

• DOI: 10.37349/ent.2023.00062
• Publication Date: 2023-12-22T09:19:55Z
• Authors: Elizabeta B. Muka...; Joe Steptoe; Matthew Critchfield; Ha-Jun Yoon; Mishaal Sharif; Qadeer Arshad
• Keywords: Neurocognitive

The currently available pharmacological anti-dementia treatments provide only temporary and limited benefits. Not surprisingly, patients professionals increasingly explore non-pharmacological interventions that may alleviate dementia symptoms. Among these is hyperbaric oxygen therapy (HBOT). A brief review presented on HBOT use in medicine, with its mode of action dementia, specifically Alzheimer’s disease, as well a case report self-initiated 63-year-old man clinical diagnosis probable disease. He had over 400 sessions [2–3 times weekly, duration 30–50 min, multi-place chamber at 2 atmospheres absolute (ATA)] 7 years donepezil (10 mg daily) for the last 3 when formally diagnosed by National Health Service (NHS) Memory Service. patient’s longitudinal neurocognitive neuroradiological evidence follow-up remained stable (with no major cognitive decline behavioral changes) compared to his initial presentation private health provider. His driving remains unimpaired, he continues be independent. This highlights potential benefits including those visuospatial ability activities daily living people argues more extensive research into effects Discussion along latest advances anti-amyloid immunotherapy augmentation current novel drug delivery via nanotechnology.